Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the serine protease inhibitor, Kunitz-Type 2 (SPINT2) gene have been associated with congenital sodium diarrhea and additional syndromic features.
|
29575628 |
2018 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
Biomarker
|
disease |
BEFREE |
Similar to other patients with CSD associated with SPINT2, this child remains dependent on parenteral nutrition for fluids and nutritional support resulting in failure to thrive.
|
28716867 |
2017 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
A Y163C mutation in the SPINT2 gene encoding the serine protease inhibitor Hepatocyte Growth Factor Inhibitor HAI-2 is associated with a congenital sodium diarrhea.
|
24722141 |
2014 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Here we establish SPINT2, previously ascribed to congenital sodium diarrhea, as a second gene associated with CTE and report molecular and immunohistochemistry data in 57 CTE patients.
|
24142340 |
2014 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Here we establish SPINT2, previously ascribed to congenital sodium diarrhea, as a second gene associated with CTE and report molecular and immunohistochemistry data in 57 CTE patients.
|
24142340 |
2014 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
Biomarker
|
disease |
BEFREE |
Here we establish SPINT2, previously ascribed to congenital sodium diarrhea, as a second gene associated with CTE and report molecular and immunohistochemistry data in 57 CTE patients.
|
24142340 |
2014 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
We delineate syndromic CSD as a distinct disease entity caused by SPINT2 loss-of-function mutations.
|
19185281 |
2009 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
We delineate syndromic CSD as a distinct disease entity caused by SPINT2 loss-of-function mutations.
|
19185281 |
2009 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
GermlineCausalMutation
|
disease |
ORPHANET |
We delineate syndromic CSD as a distinct disease entity caused by SPINT2 loss-of-function mutations.
|
19185281 |
2009 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new syndrome of tufting enteropathy and choanal atresia, with ophthalmologic, hematologic and hair abnormalities.
|
17786112 |
2007 |
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Congenital secretory diarrhea, sodium type (disorder)
|
0.750 |
Biomarker
|
disease |
CTD_human |
|
|
|
Intestinal epithelial dysplasia
|
0.350 |
Biomarker
|
disease |
BEFREE |
SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase.
|
30445423 |
2019 |
Intestinal epithelial dysplasia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
We found only one other report of an optic nerve coloboma associated with SPINT2 mutations and this occurred in a patient with congenital tufting enteropathy.
|
29575628 |
2018 |
Intestinal epithelial dysplasia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
Our data indicate that the loss of HAI-2 in Prss8R44Q/R44Q mice leads to development of progressive intestinal failure that at both histological and molecular level bears a striking resemblance to human congenital tufting enteropathy, and may provide important clues for understanding and treating this debilitating human disease.
|
29617460 |
2018 |
Intestinal epithelial dysplasia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
Recent cases of syndromic tufting enteropathy harboring the SPINT2 (19q13.2) mutation were described.
|
26684320 |
2016 |
Intestinal epithelial dysplasia
|
0.350 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
|
24142340 |
2014 |
Intestinal epithelial dysplasia
|
0.350 |
Biomarker
|
disease |
BEFREE |
Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
|
24142340 |
2014 |
Coloboma of optic disc
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We found only one other report of an optic nerve coloboma associated with SPINT2 mutations and this occurred in a patient with congenital tufting enteropathy.
|
29575628 |
2018 |
Neural Tube Defects
|
0.310 |
AlteredExpression
|
group |
BEFREE |
We found that the myristoylated alanine-rich C-kinase substrate, Kunitz-type protease inhibitor 2, and apolipoprotein B-100 protein levels were decreased in both embryos and the sera of pregnant Sprague-Dawley rats carrying embryos with NTDs.
|
28695418 |
2017 |
Neural Tube Defects
|
0.310 |
Biomarker
|
group |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |
Coloboma of optic disc
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
|
24142340 |
2014 |
Carcinoma
|
0.310 |
Biomarker
|
group |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Carcinoma
|
0.310 |
AlteredExpression
|
group |
BEFREE |
The expression of HAI-2/PB was analyzed in human normal colon mucosa, adenomas, and carcinomas.
|
10695988 |
2000 |
Diastematomyelia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |